Morfe de bullo
Resumo
Morfea bolhosa é um tipo de morphea infreqüente, por isso não há muita evidência na literatura sobre o melhor tratamento para esta condição. Apresentamos o caso de uma criança de 10 anos com diagnóstico de morféia bolhosa; Ela foi tratada com sucesso com fototerapia, calcipotriol e superóxido-dismutase
Downloads
##plugins.generic.ArticleMetadataByBiteca.languages##:
esReferências
Fett and Werth. Update on morphea, Part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. February 2011;64:217-28.
Marsol B. Update on the Classification and Treatment of Localized Scleroderma. Actas Dermosifiliogr. 2013;104(8):654-666.
Yasar S, Mumcuoglu C, Serdar Z, Gunes P. Case of Lichen Sclerosus et Atrophicus Accompanying Bullous Morphea. Ann Dermatol. 2011; Vol. 23, Suppl. 3: S354-S355.http://dx.doi.org/10.5021/ad.2011.23.S3.S354
Zwischenberger and Jacobe. A systematic review of morphea treatments and therapeutic algorithm, J Am Acad Dermatol, Nov 2011; volume 65, number 5.
Jia H, Chen X, Chi J, Zhao C, Cao Y, Zeng X, Chen X, Nanjing. A case of Bullous morphea reported in mainland China, International Journal of Dermatology. 2002; 41, 948-950.http://dx.doi.org/10.1046/j.1365-4362.2002.16672.x
Martin L, Kirsner R. Ulcers caused by bullous morphea treated with tissue-engineered skin. Dermatologic surgery. International Journal of Dermatology. 2003; 42, 402–404.http://dx.doi.org/10.1046/j.1365-4362.2003.01763.x
Fiala K, Wells M, Mullinax K, Stetson C, Paulger B. Linear Morphea Presenting as Acquired Unilateral Edema. Pediatric Dermatology. 2007; Vol. 24 No. 2 147–150.http://dx.doi.org/10.1111/j.1525-1470.2007.00363.x
Kavala M, Zindanci I, Demirkesen C, Beyhan E, Torkoglu Z. Intertriginous bullous morphea: A clue for the pathogenesis. Indian J Dermatol Venereol Leprol. July August 2007; Vol 73, Issue 4.
Kreuter A, Hyun J, Stücker M, Sommer A, Altmeyer P, Gambichler T, A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized Scleroderma, J Am Acad Dermatol. March 2006; volume 54, number 3.http://dx.doi.org/10.1016/j.jaad.2005.11.1063
Gambichler T, Terras S, Kreuter A, Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: Facts and controversies. Clinics in Dermatology. 2013; 31, 438–454.http://dx.doi.org/10.1016/j.clindermatol.2013.01.011
Sator P, Radakovic S, Schulmeister K, Hönigsmann H, Tanew A. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol. May 2009;Volume 60;number 5;786-791.http://dx.doi.org/10.1016/j.jaad.2008.12.013
Kroft E, Berkhof N, Van de Kerkhof P, Gerritsen R, Jong E, Ultraviolet A phototherapy for sclerotic skin diseases: A systematic review. J Am Acad Dermatol 2008; volume 59, number 6, 1017-1030.http://dx.doi.org/10.1016/j.jaad.2008.07.042
Cunningham B, Landells I, Langman C, Sailer D, Paller A. Topical calcipotriene for morphea/linear scleroderma. Journal of the American Academy of Dermatology. August 1998;39:211-5.http://dx.doi.org/10.1016/S0190-9622(98)70077-5
Jablonska S, Blaszczyk M, Scleroderma and Sclerotic Skin Conditions: Unapproved Treatments. Clinics in Dermatology Y 2002;20:634–637.http://dx.doi.org/10.1016/S0738-081X(02)00283-3
Shahriari M, Kerr P, Slade K, Grant-Kels J. Vitamin D and the skin. Clinics in Dermatology. 2010; 28: 663–668.http://dx.doi.org/10.1016/j.clindermatol.2010.03.030
Parish J, Topical Vitamin D3 Analogues: Unapproved Uses, Dosages, or Indications. Clinics in Dermatology Y 2002;20:558–562.http://dx.doi.org/10.1016/S0738-081X(02)00269-9
Nagai M, Hasegawa M, Takehara K, Sato S. Novel Autoantibody to Cu/Zn Superoxide Dismutase in Patients with Localized Scleroderma. J Invest Dermatol. 2004:122:594 –601.http://dx.doi.org/10.1111/j.0022-202X.2004.22333.x
Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Serum levels of manganese superoxide dismutase in patients with localized scleroderma. Exp Dermatol. 2004: 13: 357–360.http://dx.doi.org/10.1111/j.0906-6705.2004.00160.x
Treiber N, Peters T, Sindrilaru A, Huber R, Kohn M, Menke A, Briviba K, Kreppel F, Basu A, Maity P, Koller M, Iben S, Wlaschek M, Kochanek S, Scharffetter-Kochane K. Overexpression of manganese superoxide dismutase in human dermal fibroblasts enhances the contraction of free floating collagen lattice: implications for ageing and hyperplastic scar formation. Arch Dermatol Res. 2009: 301:273–287.http://dx.doi.org/10.1007/s00403-009-0935-9
Storz and Imlay. Oxidative stress. Current Opinion in Microbiology 1999, 2:188-l 94.
